SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.570+0.6%Nov 10 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (6793)2/19/2000 3:21:00 PM
From: Hank  Read Replies (2) of 10293
 
It really galls you that Bill won't agree with you, doesn't it? LOL! I can't wait until GUMM fails miserably. Imagine all the repetitive BS we WON'T have to wade through anymore!

Zicam is not proven.

Studies on Zicam are statistically insignificant, hence they will NEVER be published in a major medical journal such as NEJM (what ever happened to that one Danny?).

GUMM profits will drop like a rock after this cold season is over and consumers realize that Zicam is ineffective and not worth the expense, discomfort, or trouble.

GUMM fundamentals will follow the same trajectory as Quigley- DOWN. Their stock price will undoubtedly follow.

By next cold season , there will be at least a half dozen Zicam knockoffs on the shelves and GUMM will find itself in litigation hell trying to sue everybody. That will only confuse the issue for consumers and help propel GUMM's financial decline.

GUMM's other products will never generate any significant revenues. Nicotine gum? Give me a break. They only have about a dozen better quality products to help you quit smoking to compete with that have been on the market for quite a while now INCLUDING other brands of nicotine gum.

In short, GUMM is a POS!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext